2 weeks Ago By ABMN Staff
Tempus AI ( NASDAQ:TEM – Get Free Report ) was downgraded by Stifel Nicolaus from a “buy” rating to a “hold” rating in a note issued to investors on Monday, MarketBeat reports. They currently have a $65.00 price objective on the stock, up from their prior price objective of $45.
00. Stifel Nicolaus’ price target would indicate a potential downside of 4.47% from the stock’s current price.
Other analysts have also recently issued research reports about the stock. Loop Capital raised their price objective on shares of Tempus AI from $48.00 to $57.
00 and gave the company a “buy” rating in a research note on Tuesday, October 15th. Needham & Company LLC reaffirmed a “buy” rating and issued a $47.00 target price on shares of Tempus AI in a report on Wednesday, August 7th.
JPMorgan Chase & Co. boosted their price target on Tempus AI from $42.00 to $47.
00 and gave the stock an “overweight” rating in a research note on Wednesday, August 7th. Piper Sandler began coverage on Tempus AI in a research note on Monday, August 12th. They issued a “neutral” rating and a $40.
00 price objective for the company. Finally, Bank of America cut Tempus AI from a “buy” rating to a “neutral” rating and lifted their price objective for the stock from $45.00 to $60.
00 in a report on Wednesday, October 2nd. Three equities research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company. Based on data from MarketBeat.
com, the company currently has a consensus rating of “Moderate Buy” and an average price target of $54.22. View Our Latest Report on Tempus AI Tempus AI Price Performance Institutional Trading of Tempus AI Institutional investors and hedge funds have recently made changes to their positions in the stock.
EFG Asset Management North America Corp. acquired a new position in shares of Tempus AI in the second quarter valued at approximately $1,333,000. ARK Investment Management LLC purchased a new position in shares of Tempus AI during the 2nd quarter worth $18,294,000.
Northwestern University acquired a new stake in shares of Tempus AI during the second quarter worth $491,000. Alphabet Inc. purchased a new stake in shares of Tempus AI in the second quarter valued at $54,289,000.
Finally, Pier Capital LLC acquired a new position in Tempus AI in the second quarter valued at $2,301,000. About Tempus AI ( Get Free Report ) Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.
See Also Receive News & Ratings for Tempus AI Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tempus AI and related companies with MarketBeat.com's FREE daily email newsletter ..
